SCHEMBL363768

SCHEMBL363768

COc1ccc(C(=O)/C=C/c2ccc(OC)nc2)c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
HPGD P15428 2/20 0.63
ALDH1A1 P00352 1/20 0.62
GAA P10253 1/20 0.62
ALOX12 P18054 1/20 0.62
CTSL P07711 1/20 0.55
ABCG2 Q9UNQ0 7/20 0.54
MAPT P10636 3/20 0.53
CYP3A4 P08684 3/20 0.53
APP P05067 3/20 0.53
MAPK1 P28482 1/20 0.53
CYP2C19 P33261 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TNFRSF1A P19438 1/20 0.53
FLT3 P36888 1/20 0.52
CYP1A1 P04798 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364142 0.88 LMNA (0.50) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL363978 0.87 CXCL12 (0.64) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL364871 0.87 MEN1 (0.47) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL4774099 0.85 MEN1 (0.74) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL365186 0.84 ABCG2 (0.51) LMNAMEN1KMT2AALDH1A1ABCG2
SCHEMBL25196696 0.81 MEN1 (0.63) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL363719 0.80 LMNA (0.52) LMNAKMT2AHPGDALDH1A1GAA
SCHEMBL25205853 0.79 APP (0.75) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL364403 0.78 SMN1; SMN2 (0.50) LMNAMEN1KMT2AHPGDALDH1A1
P-Methoxy-Acetophenone SCHEMBL4774853 0.78 MEN1 (0.65) LMNAMEN1KMT2AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 LMNA 2651/4885MEN1 1315/4885KMT2A 3981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.